This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Natus Medical Inc (BABY)

NASDAQ: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 344.11M 292.28M 232.65M 218.66M
Cost of Sales 129.23M 116.20M 91.76M 79.54M
Gross Operating Profit 214.88M 176.08M 140.90M 139.11M
Selling, General, and Administrative Expenses 135.68M 128.25M 95.87M 90.84M
Research & Development 32.07M 29.97M 25.56M 21.28M
Operating Income before D & A (EBITDA) 47.13M 17.87M 19.47M 26.99M
Depreciation & Amortization 12.85M 12.62M 10.02M 9.16M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -1.04M -346.00K 38.00K 10.00K
Special Income / Charges 0.00 0.00 -20.00M 0.00
Total Income Before Interest Expenses (EBIT) 33.24M 4.91M -10.52M 17.84M
Interest Expense 1.68M 489.00K 268.00K 128.00K
Pre-Tax Income 31.56M 4.42M -10.78M 17.71M
Income Taxes 8.68M 536.00K 912.00K 5.79M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 22.88M 3.88M -11.70M 11.92M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 22.88M 3.88M -11.70M 11.92M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 22.88M 3.88M -11.70M 11.92M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
22.88M 3.88M 8.30M 11.92M
Preferred Dividends
Net Income Available To Common 22.88M 3.88M -11.70M 11.92M
Basic EPS from Continuing Ops. 0.76 0.13 -0.41 0.42
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.76 0.13 -0.41 0.42
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.76 0.13 -0.41 0.42
Basic Normalized Net Income/Share 0.76 0.13 0.29 0.42
EPS fr Continuing Ops. 0.74 0.13 -0.41 0.41
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.74 0.13 -0.41 0.41
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.74 0.13 -0.41 0.41
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.74 0.13 0.29 0.41
Dividends Paid per Share 0.00 0.00 0.00 0.00
BABY News

BABY Natus Medical Inc

Analysts Ratings for BABY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BABY ANALYST REPORT

Brokerage Partners

BABY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs